Last updated: 2026-09-14 20:23:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
McKesson Corporation (MCK) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NYSE. The stock is currently priced at $911.17, with a market capitalisation of $102.78B and a P/E ratio of 22.38. Over the past 52 weeks, its price has ranged from $687.68 to $999.00. This page covers its latest market performance, valuation, price trends and company information.
$102.78B | |
$900.00 | |
$999.00 | |
$22.61 | |
$881.51 | |
509.98K | |
1.03M | |
22.38 | |
$999.00 | |
$687.68 | |
0.38% | |
-- |
McKesson Corporation (MCK) is trading at $911.09 in after-hours trading as of 2026-09-14 20:21:00, up 3.36% ($29.58) from the regular-session close of $881.51.
After-hours trading shows how investors are pricing MCK after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, McKesson Corporation (MCK) moved from $924.78 to $911.17, representing a decline of 1.47% ($13.61).
The stock traded between $874.31 and $929.95 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 859.23 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 71.8%
MCK is currently trading at $911.17, placing it 71.8% of the way from its 52-week low of $687.68 to its 52-week high of $999.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Employees | 43000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of McKesson Corporation (MCK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.